Last reviewed · How we verify

NCT05221099

Reliability and Validity of Urdu Version of Mini-BESTest in Persons With Parkinson's Disease

Completed Last updated 10 March 2022
What this trial tests

trial in Balance in 80 participants. Completed in 15 February 2022.

Timeline
30 May 2021
Primary endpoint
5 February 2022
15 February 2022

Quick facts

Lead sponsorRiphah International University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date30 May 2021
Primary completion5 February 2022
Estimated completion15 February 2022
Sites1 location across Pakistan

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 50 to 70, any sex, with Balance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Various clinical scales are available to investigate balance impairment, Mini-BESTest is one of them. Thus, this study aims to translate the Mini-BESTest into Urdu and investigate its psychometric properties in the Pakistani Parkinson's population with dynamic balance impairment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Balance

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05221099.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing